(Press-News.org) Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
"Pancreatic cancer is one of the major causes of cancer death globally, with a 5-year survival rate of less than 5 percent. The outlook for those patients who can undergo surgical resection is better, and in specialized centers, resection rates greater than 15 percent can be achieved. Although surgery cannot guarantee a cure, the 5-year survival does improve to around 10 percent following resection. There is a clear need to improve long-term survival in these patients," the authors write.
John P. Neoptolemos, M.D., of the University of Liverpool, U.K., and colleagues conducted a study to determine whether fluorouracil or gemcitabine is superior in terms of overall survival as adjuvant (supplemental) chemotherapy treatment following resection of pancreatic cancer. The European Study Group for Pancreatic Cancer (ESPAC)-3 trial was conducted in 159 pancreatic cancer centers in Europe, Australasia, Japan, and Canada. Included in ESPAC-3 version 2 (the trial was modified) were 1,088 patients with pancreatic ductal adenocarcinoma who had undergone cancer resection; patients were randomized between July 2000 and January 2007 and underwent at least 2 years of follow-up. Patients received either fluorouracil plus folinic acid (leucovorin, an active metabolite of folic acid, which counteracts some of the toxic effects of some chemotherapy drugs) (n = 551) or gemcitabine (n = 537) for 6 months.
During the trial, 753 patients (69 percent) had died at the time of analysis (388 [70 percent] in the fluorouracil plus folinic acid group and 365 [68 percent] in the gemcitabine group). Median (midpoint) length of follow-up of 335 living patients was 34.2 months, equal across treatment groups. Overall, 282 of patients remaining alive (84 percent) had undergone follow-up for more than 2 years. Median survival for patients treated with fluorouracil plus folinic acid was 23.0 months and for patients treated with gemcitabine was 23.6 months.
Estimates of survival at 12 and 24 months were 78.5 percent and 48.1 percent, respectively, for the fluorouracil plus folinic acid group and 80.1 percent and 49.1 percent for the gemcitabine group. Analysis indicated no statistically significant difference in survival estimates between the treatment groups.
"Seventy-seven patients (14 percent) receiving fluorouracil plus folinic acid had 97 treatment-related serious adverse events, compared with 40 patients (7.5 percent) receiving gemcitabine, who had 52 events. There were no significant differences in either progression-free survival or global quality-of-life scores between the treatment groups," the authors write.
"In conclusion, gemcitabine did not result in improved overall survival compared with fluorouracil plus folinic acid in patients with resected pancreatic cancer."
(JAMA. 2010;304[10]:1073-1081. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Refinement of Adjuvant Therapy for Pancreatic Cancer
Eileen M. O'Reilly, M.D., of Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, writes in an accompanying editorial that while the results of this study provides important information, there is still much work to be done regarding effective treatments for pancreatic cancer.
"Adjuvant therapy for resected pancreatic adenocarcinoma is now firmly established as offering a modest but real improvement in overall survival at 5 years with about double the number of patients alive compared with no treatment. Much attention has been paid to improving adjuvant clinical trial design, in particular excluding patients who have undergone palliative resections from adjuvant studies and streamlining other eligibility criteria. The ESPAC investigators have significantly contributed to the establishment of standard adjuvant therapy."
"Results from the ongoing European and U.S. studies will further refine practice over the next decade; however, there is much to be done including identification of new and active drugs for treating pancreatic cancer that may be translated into the adjuvant setting. Other directions deserving further evaluation include the role of neoadjuvant or preoperative therapy for patients with resectable pancreatic adenocarcinoma, an approach that offers several theoretical advantages over an adjuvant approach. Even though pancreatic cancer remains one of the most challenging malignancies, the next decade looks incrementally brighter."
INFORMATION:
(JAMA. 2010;304[10]:1124-1125. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
After resection, common treatment of pancreatic cancer as effective as chemotherapy drug dose
2010-09-08
ELSE PRESS RELEASES FROM THIS DATE:
Smoking damages men's sperm and also the numbers of germ and somatic cells in developing embryos
2010-09-08
Two new studies have shed more light on how smoking may damage fertility, and give further weight to advice that mothers and fathers-to-be should stop smoking before attempting to conceive. The research is published online in Europe's leading reproductive medicine journal Human Reproduction today (Wednesday 8 September).
In the first study [1], researchers found that a mother's smoking during early pregnancy dramatically reduces the numbers of germ cells (the cells that form eggs in females and sperm in males) and somatic cells (the cells that form every other part of ...
Virginia Tech researchers contribute to turkey genome sequencing
2010-09-08
An international consortium of researchers has completed the majority of the genome sequence of the domesticated turkey, thanks in part to the efforts of Virginia Tech faculty members.
The research team will publish "Multi-Platform Next-Generation Sequencing of the Domestic Turkey (Meleagris gallopavo): Genome Assembly and Analysis" in the journal PLoS Biology (Public Library of Science) on Sept. 7, 2010.
"To date, more than 90 percent of the domesticated turkey genome has been sequenced and assembled," said Rami Dalloul, assistant professor of animal and poultry sciences ...
Potomac River: 10-fold increase in native submerged vegetation reflects improved water quality
2010-09-08
The Potomac River in Washington, D.C. is showing multiple benefits from restoration efforts, newly published research suggests. Reduced nutrients and improved water clarity have increased the abundance and diversity of submerged aquatic vegetation (SAV) in the Potomac, according to direct measurements taken during the 18-year field study.
Since 1990, the area covered by SAV in the lower Potomac has doubled, the area covered by native SAV has increased ten-fold, the diversity of plant species has increased, and the proportion of exotic species to native species has declined ...
Mapping a brain atlas
2010-09-08
Uncovering the secrets of the brain requires an intense network of collaborative research. Building on a tool that was co-developed in his laboratory and described in a recent issue of Brain, Dr. Yaniv Assaf of Tel Aviv University's Department of Neurobiology is collaborating with an international team of scientists to understand how different parts of the human brain "connect" -- and to turn this information into a "brain atlas."
Brain researchers already know that autism and schizophrenia are not localized disorders ––there is no one place in the brain they can be found. ...
Researchers at Children's Hospital Los Angeles find diet-induced obesity accelerates leukemia
2010-09-08
LOS ANGELES (September 7, 2010) – The first study to demonstrate that obesity can directly accelerate the progression of acute lymphoblastic leukemia (ALL) has been conducted at The Saban Research Institute of Childrens Hospital Los Angeles and will be published in Cancer Prevention Research, on October 5, 2010. Obesity has been associated with an increased incidence of many cancers, including leukemia, but it has been unknown whether the increase in incidence was a direct effect of obesity or associated with genetic, lifestyle, health, or socio-economic factors.
"Given ...
Mount Sinai researchers find new target to improve pain management
2010-09-08
Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling.
Overcoming tolerance to morphine after chronic administration has been a persistent problem in treating patients with severe pain, including those with cancer and neuropathy and recovering from major surgeries. ...
Study: Teasing about weight can affect pre-teens profoundly
2010-09-08
Schoolyard taunts of any type can potentially damage a child's sense of self-confidence. But a new study suggests that a particular kind of teasing – about weight – can have distinctive and significant effects on how pre-teens perceive their own bodies.
The research, among the first to specifically examine the impact of weight-based criticism on pre-adolescents, also hints that the practice can cause other health and emotional issues for its victims.
"We tend to think of adolescence as the time when kids become sensitive about their body image, but our findings suggest ...
Personality predicts cheating more than academic struggles, study shows
2010-09-08
WASHINGTON — Students who cheat in high school and college are highly likely to fit the profile for subclinical psychopathy – a personality disorder defined by erratic lifestyle, manipulation, callousness and antisocial tendencies, according to research published by the American Psychological Association. These problematic students cheat because they feel entitled and disregard morality, the study found.
Cheating, a perennial concern for educators, "has been facilitated by new technologies," said Delroy Paulhus, PhD, who led the research. "At the same time, cheating may ...
Restoring coastal wetlands? Check the soil
2010-09-08
MADISON, WI, September 7, 2010 – Rising sea levels and coastal development are threatening coastal freshwater wetlands with saltwater intrusion. While most ecosystem restoration projects have focused on surface water and groundwater, new research finds that conditions in the vadose zone, the unsaturated soil below the surface but above the water table, are of particular importance to seedling survival in coastal floodplain ecosystems.
Scientists at the University of Florida, the South Florida Water Management District (SFWMD), and the Florida Park Service investigated ...
Computer-based video analysis boosts data gathering in behavioral studies
2010-09-08
PROVIDENCE, R.I. [Brown University] — For decades, carefully logging data about how mice go through the motions of their daily routines has been a tedious staple of behavioral and neuroscience research:
Hour 2, minute 27: mouse 4 is sleeping;
Hour 3, minute 12: mouse 7 is eating;
and so on. It's a task most people would happily cede to automation. Now, says Thomas Serre, assistant professor of cognitive, linguistic and psychological sciences at Brown University, that's finally possible.
In a paper to be published online Sept. 7, 2010, in the journal Nature ...